jamunjar-logo
whatsapp
cartmembermenu
Search for
"test & packages"
"physiotherapy"
"heart"
"lungs"
"diabetes"
"kidney"
"liver"
"cancer"
"thyroid"
"bones"
"fever"
"vitamin"
"iron"
"HTN"

Pus Routine Microscopy

Bacterial/ Viral
image

Report in 12Hrs

image

At Home

nofastingrequire

No Fasting Required

Details

Measures presence and quantity of pus cells (polymorphonuclear leukocytes)

359500

28% OFF

Pus Routine Microscopy - Comprehensive Medical Test Guide

  • Why is it done?
    • Test measures the cellular and bacterial composition of purulent material (pus) collected from infected tissues, wounds, abscesses, or body cavities
    • Diagnoses bacterial, fungal, or parasitic infections by identifying the causative organisms present in the pus sample
    • Helps determine the severity and type of infection through assessment of white blood cell (WBC) count and differential
    • Ordered when patients present with localized infections including abscesses, boils, infected wounds, drainage, or inflammatory conditions
    • Used to guide appropriate antibiotic or antimicrobial therapy selection
    • Performed when purulent discharge is evident from wounds, surgical sites, or drainage tubes
  • Normal Range
    • WBC Count: Absence of significant numbers (Normal: <5-10 cells/HPF or <1000 cells/μL in non-infected material)
    • RBC Count: Absent or minimal (Normal: <5 cells/HPF unless contaminated with blood)
    • Bacteria: Absent (normal, sterile sample)
    • Fungi: Absent
    • Parasites: Absent
    • Epithelial Cells: Few to none (if numerous, indicates contamination)
    • Crystals: Absent
    • Interpretation: Negative result indicates absence of infection or contamination; Positive result indicates active infection requiring treatment
  • Interpretation
    • Elevated WBC Count (>25-50 cells/HPF or >5000 cells/μL):
      • Indicates active bacterial or pyogenic infection
      • Predominance of neutrophils suggests acute bacterial infection
      • Increased lymphocytes may indicate chronic or viral infection
    • Presence of Bacteria:
      • Few bacteria: Early or partially treated infection
      • Moderate bacteria: Active infection requiring intervention
      • Numerous bacteria: Severe infection, high organism load
      • Gram-positive cocci: Staphylococcus, Streptococcus species
      • Gram-negative rods: Escherichia coli, Pseudomonas, Klebsiella species
    • Fungal Elements:
      • Presence indicates fungal infection (Candida, Aspergillus, etc.)
      • More common in immunocompromised patients
    • Presence of RBCs:
      • Indicates contamination with blood or recent hemorrhage in infected area
    • Numerous Epithelial Cells:
      • Suggests poor sample collection or contamination; specimen validity questionable
    • Factors Affecting Results:
      • Antibiotics administered before sample collection may reduce organism visibility
      • Improper sample collection or storage may compromise results
      • Immunocompromised status may alter inflammatory cell patterns
      • Stage of infection (acute vs. chronic) affects cell types and counts
  • Associated Organs
    • Primary Organ Systems Involved:
      • Integumentary system (skin, subcutaneous tissue): abscesses, boils, cellulitis
      • Musculoskeletal system (muscle, bone): osteomyelitis, pyogenic infections
      • Genitourinary system: urogenital tract infections, prostatic abscesses
      • Gastrointestinal system: anal fistulas, perirectal abscesses
      • Respiratory system: lung abscesses, empyema
      • Nervous system: spinal epidural abscess, brain abscess
    • Diseases Commonly Diagnosed:
      • Bacterial abscess (Staphylococcus aureus, Streptococcus pyogenes)
      • Infected wounds and surgical site infections
      • Cellulitis and pyogenic infections
      • Osteomyelitis (bone infections)
      • Tuberculosis (granulomatous infections)
      • Fungal infections (Candidiasis, Aspergillosis in immunocompromised)
      • Parasitic infections (toxoplasmosis, amebic abscess)
    • Potential Complications from Abnormal Results:
      • Septicemia or bacteremia if infection spreads systemically
      • Septic shock in severe infections with delayed treatment
      • Tissue necrosis and permanent scarring if treatment delayed
      • Abscess rupture causing spread of infection to adjacent tissues
      • Antibiotic resistance if inappropriate therapy selected
  • Follow-up Tests
    • Recommended Based on Positive Results:
      • Pus Culture and Sensitivity (C&S) - Identify specific organism and antibiotic susceptibility for targeted therapy
      • Gram Staining - Differentiate bacteria types (gram-positive vs. gram-negative) for preliminary identification
      • Special Staining (AFB for tuberculosis, fungal stains) - If specific organisms suspected
      • Blood Culture - If systemic infection or bacteremia suspected
      • Complete Blood Count (CBC) - Assess systemic inflammatory response
    • Imaging Studies:
      • Ultrasound - Identify abscess location, size, and determine drainage necessity
      • CT or MRI - Evaluate deep-seated infections or complications
      • X-ray - For osteomyelitis or gas-forming infections
    • Monitoring Tests:
      • Repeat pus microscopy after 48-72 hours of treatment to assess response
      • CRP (C-Reactive Protein) and Procalcitonin - Monitor infection severity and treatment response
      • ESR (Erythrocyte Sedimentation Rate) - Monitor chronic infection resolution
    • Related Complementary Tests:
      • Serology or PCR - For specific pathogen identification (TB, fungal serology)
      • Wound Swab Culture - If drainage accessible without aspiration
  • Fasting Required?
    • Fasting: NO - Fasting is not required for pus microscopy
    • Sample Collection: Pus or exudate aspirated directly from the infected site
    • Specimen Collection Method:
      • Needle aspiration - Preferred method for deep abscesses; use sterile needle and syringe
      • Swab collection - For surface wounds or drainage; use sterile cotton or synthetic swabs
      • Container: Sterile leak-proof container with appropriate transport media
    • Patient Preparation:
      • No special pre-procedure fasting or dietary restrictions
      • Skin antisepsis required at collection site (typically 70% alcohol or povidone-iodine)
      • Allow antiseptic to dry (minimum 30 seconds) before sample collection
      • Avoid contamination with skin flora or surrounding tissue
    • Medications to Avoid:
      • If possible, defer antibiotics until after sample collection for optimal organism recovery
      • If already on antibiotics, note the medication and duration on the specimen requisition
      • Avoid topical antiseptics or antibiotics on the collection site immediately before sampling
    • Sample Handling & Transport:
      • Send sample to laboratory immediately (within 30 minutes if possible)
      • Maintain room temperature or incubate at 35-37°C during transport (do not refrigerate)
      • Ensure proper labeling with patient name, ID, collection date/time, and specimen source
      • Include relevant clinical information (infection site, antibiotics received, immunocompromised status)

How our test process works!

customers
customers